We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

67 hedge funds and large institutions have $170M invested in Minerva Neurosciences in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

0.7% more ownership

Funds ownership: 8.38% → 9.08% (+0.7%)

4% less funds holding

Funds holding: 70 → 67 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

22% less capital invested

Capital invested by funds: $217M → $170M (-$46.7M)

Holders
67
Holders Change
-3
Holders Change %
-4.29%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
21
Reduced
19
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$1.67M
2
HCMT
Highland Capital Management (Texas)
Texas
+$1.38M
3
SFM
Sphera Funds Management
Israel
+$930K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$403K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$336K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.08M
2
NC
Nexthera Capital
New York
-$4.08M
3
JGC
J. Goldman & Co
New York
-$1.19M
4
NFA
Nationwide Fund Advisors
Ohio
-$950K
5
Renaissance Technologies
Renaissance Technologies
New York
-$858K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$79K -$28.8K -580 -26%
Teacher Retirement System of Texas
52
Teacher Retirement System of Texas
Texas
$66K +$67.6K +1,364 New
VOYA Investment Management
53
VOYA Investment Management
Georgia
$65K – – –
Citigroup
54
Citigroup
New York
$63K +$49.1K +991 +303%
KAM
55
Kazazian Asset Management
Florida
$63K +$64.5K +1,301 New
Bank of America
56
Bank of America
North Carolina
$54K -$17.3K -348 -24%
Legal & General Group
57
Legal & General Group
United Kingdom
$47K -$9.77K -197 -17%
Barclays
58
Barclays
United Kingdom
$35K +$32.5K +656 +772%
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$32.7K +$5.55K +112 +20%
Parallax Volatility Advisers
60
Parallax Volatility Advisers
California
$26K +$26.6K +536 New
Canada Life
61
Canada Life
Manitoba, Canada
$16K – – –
AIP
62
Ameritas Investment Partners
Nebraska
$13K – – –
DCM
63
Delpha Capital Management
New York
$7K +$7.64K +154 New
MAM
64
Meeder Asset Management
Ohio
$4K +$545 +11 +18%
PCM
65
Poehling Capital Management
Wisconsin
$1K +$1.24K +25 New
Walleye Trading
66
Walleye Trading
New York
$77 +$78.6K +1,586 New
NC
67
Nexthera Capital
New York
– -$4.08M -67,112 Closed
JGC
68
J. Goldman & Co
New York
– -$1.19M -19,590 Closed
NFA
69
Nationwide Fund Advisors
Ohio
– -$950K -15,624 Closed
SCM
70
Sterling Capital Management
North Carolina
– -$396K -6,517 Closed
VEA
71
Virtus ETF Advisers
New York
– -$260K -4,273 Closed
AQR Capital Management
72
AQR Capital Management
Connecticut
– -$140K -2,298 Closed
GCP
73
GSA Capital Partners
United Kingdom
– -$122K -2,000 Closed
VF
74
Virtu Financial
New York
– -$116K -1,902 Closed
Russell Investments Group
75
Russell Investments Group
United Kingdom
– -$112K -1,834 Closed
1 2
3
4

NERV Hedge Fund Activity: Q4 2017 in Review

67 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2017, worth a combined $170M — down 22% from $217M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of NERV and 11 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 21 added.

The largest buyer was JP Morgan Chase, adding an estimated $1.67M. The largest seller was Fidelity Investments, cutting an estimated $6.08M.

  • 67 institutional investors held Minerva Neurosciences (NERV) as of Q4 2017, down from 70 in Q3 2017.
  • Funds reported $170M of Minerva Neurosciences stock for Q4 2017, down 22% quarter-over-quarter.
  • 11 funds opened new Minerva Neurosciences positions in Q4 2017 and 14 closed out, a net change of -3 holders.
  • The largest Minerva Neurosciences buyer in Q4 2017 was JP Morgan Chase, an estimated $1.67M added.
  • The largest Minerva Neurosciences seller in Q4 2017 was Fidelity Investments, an estimated $6.08M sold.

Based on aggregated 13F filings for Q4 2017.